Katarzyna Kniola: Proud to Share My First Scientific Publication in Haemophilia
Katarzyna Kniola, Senior Specialist Biomedical Scientist – Haematology and Blood Transfusion at Barts Health NHS Trust, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Haemophilia, adding:
“I’m incredibly excited to share a very special milestone in my career — my first scientific publication!
I’m proud to have contributed as a co-author to our paper, ‘The Correction Factor for Monitoring Efanesoctocog Alfa Is Not Always 2.5′, published in Haemophilia.
Our study highlights the limitations of applying a universal correction factor when monitoring efanesoctocog alfa (Altuvoct), demonstrating the importance of assay-specific validation to ensure accurate FVIII measurements and support clinical decision-making.
As a Biomedical Scientist specialising in Haemostasis, being involved in research that has the potential to influence laboratory practice is incredibly rewarding.
A huge thank you to my co-authors and everyone involved for the opportunity to contribute to this work.
Seeing my name on a published scientific paper for the very first time is definitely a moment I’ll remember!”
Title: The Correction Factor for Monitoring Efanesoctocog Alfa Is Not Always 2.5
Authors: Sean Platton, Jude Platton, Katarzyna Kniola, Laura Aiken, Janine Collins, Suthesh Sivapalaratnam, Priyanka Raheja
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 31, 2026, 19:53Mohammad Vahabi: Exploring the Role of JAK Inhibitors in Urticarial Vasculitis
-
Oct 31, 2026, 19:50Agata Sobczynska-Malefora: How Age and Ethnicity Influence Active Vitamin B12 and MMA Levels
-
Oct 31, 2026, 19:47David Shoultz: Running for MPN Research at the ASH Annual Meeting
-
Oct 31, 2026, 19:40Andreas Calatzis: Revisiting a Widely Cited Study on Preoperative Screening for Primary Hemostasis Disorders
-
Oct 31, 2026, 19:40How Antiseizure Medication Selection May Influence DOAC Safety in Epilepsy – JAMA Neurology
-
Oct 31, 2026, 19:35Alejandro González Veliz: Balancing Ischemic Protection and Bleeding Risk in Antiplatelet Management
-
Oct 31, 2026, 19:29Sascha David: Therapeutic Plasma Exchange Associated with Lower 90 Day Mortality in Streptococcal Septic Shock
-
Oct 31, 2026, 19:25Jessica Garcia: Real-World Evidence on Efanesoctocog Alfa Prophylaxis in Pediatric Hemophilia A
-
Oct 31, 2026, 19:21Cedric Hermans: What If Higher Plasma FIX Levels Do Not Necessarily Mean better Haemostatic Protection?